TG Therapeutics Inc (TGTX)

Net profit margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income US$ in thousands 12,672 -198,335 -348,101 -279,381 -172,870
Revenue US$ in thousands 221,047 2,785 6,689 152 152
Net profit margin 5.73% -7,121.54% -5,204.08% -183,803.29% -113,730.26%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $12,672K ÷ $221,047K
= 5.73%

TG Therapeutics Inc's net profit margin has shown significant fluctuations over the past five years. In particular, the company experienced extremely negative net profit margins in 2020 and 2019, indicating substantial losses relative to its revenue during those years. However, there was a notable improvement in profitability in 2021 and 2022, where the net profit margins were negative but not as severely as in the previous years. In 2023, the company achieved a positive net profit margin of 5.73%, signifying a profit relative to its total revenue for that year. Overall, the trend in net profit margin shows variability in the company's ability to generate profits, with the most recent year displaying a more favorable financial performance compared to the preceding years.


Peer comparison

Dec 31, 2023